ERYTHROID DIFFERENTIATION IS SUPPRESSED BY RIBAVIRIN DURING COMBINATION THERAPY WITH PEGYLATED INTERFERON-α2A IN CHRONIC HEPATITIS C: AN IN VITRO AND IN VIVO STUDY
Digestive and Liver Disease - Netherlands
doi 10.1016/s1590-8658(09)60131-6
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2009
Authors
Publisher
Elsevier BV